UACA antibody
Quick Overview for UACA antibody (ABIN6296769)
Target
See all UACA AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Mouse anti-Human/Mouse UACA Antibody [Sodium Azide Free]
-
Specificity
- Nuclear membrane
-
Purification
- Nuclei of myeloid leukemia biopsy cells were used as the immunogen for the UACA antibody.
-
Immunogen
- Nuclei of myeloid leukemia biopsy cells were used as the immunogen for the UACA antibody.
-
-
-
-
Application Notes
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 0.5-1 μg/mL
Western blot: 0.5-1 μg/mL -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- UACA (Uveal Autoantigen With Coiled Coil Domains And Ankyrin Repeats (UACA))
-
Alternative Name
- Uveal autoantigen with coiled-coil domains and ankyrin repeats
-
Background
-
Target Description: UACA (Uveal Autoantigen with Coiled-coil domains and Ankyrin repeats) is a 1,416 amino acid nuclear membrane protein. It was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves' disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
Gene Symbol: UACA///KIAA1561
-
Gene ID
- 55075
-
UniProt
- Q9BZF9
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-